De León, Marina E. https://orcid.org/0000-0001-9973-1951
Fox, Eduardo G. P. https://orcid.org/0000-0001-6141-255X
Dunaj, Sara https://orcid.org/0000-0002-2623-7327
Jenner, Ronald A. https://orcid.org/0000-0002-3297-2408
Keiser, Carl N. https://orcid.org/0000-0002-4936-7810
Macrander, Jason https://orcid.org/0000-0002-1509-4332
Nixon, Samantha A. https://orcid.org/0000-0003-3157-4114
Nobile, Clarissa J. https://orcid.org/0000-0003-0799-6499
Petras, Daniel https://orcid.org/0000-0002-6561-3022
Rodriguez-Roman, Eduardo https://orcid.org/0000-0001-8717-7527
Saviola, Anthony J. https://orcid.org/0000-0001-6890-512X
Trim, Steven A. https://orcid.org/0000-0002-3524-4115
Varona, Natascha S. https://orcid.org/0000-0001-8783-3301
Yeager, Justin https://orcid.org/0000-0001-8692-6311
Ul-Hasan, Sabah https://orcid.org/0000-0001-6334-452X
Herzig, Volker https://orcid.org/0000-0003-2514-3983
Colston, Timothy J. https://orcid.org/0000-0002-1127-1207
Funding for this research was provided by:
National Science Foundation (2334779)
National Science Foundation (2406685)
CNPQ (317847/2021-0)
National Institute of General Medical Sciences (R35GM124594)
Australian Research Council (FT190100482)
UDLA (483.A.XIV.24)
Article History
Received: 24 July 2024
Accepted: 24 December 2024
First Online: 27 March 2025
Declaration
:
: Clarissa J. Nobile is a cofounder and acting CEO of BioSynesis, Inc., a company developing diagnostics and therapeutics for biofilm infections. Steven A. Trim was the founder and CSO at Venomtech Ltd., a company selling venom libraries for research.